Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Safety and Tolerability of Lentil Protein Hydrolysate in Healthy Males and Females Whilst Exploring the Effects of a Dose Range on Blood Pressure Control and Vascular Function and Exercise Performance

NCT06894875 is registered in ClinicalTrials.gov with Nuritas Ltd as lead sponsor.

NCT NCT06894875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06894875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Safety and Tolerability of Lentil Protein Hydrolysate in Healthy Males and Females Whilst Exploring the Effects of a Dose Range on Blood Pressure Control and Vascular Function and Exercise Performance
Lead sponsor
Nuritas Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
June 24, 2025
Completion date
March 30, 2026
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, exercise, exercise performance, safety and tolerability in healthy volunteers, vascular function in healthy volunteers, vasodilation